Showing results (101-110 of 173) with videos related to

Sort By:
Pageof 18
The Journal of Pathology|August 11, 2023
Intestinal overgrowth of Candida albicans exacerbates bleomycin-induced pulmonary fibrosis in mice with dysbiosisTakahiro Yamada, Taku Nakashima, Takeshi Masuda, et al.
Disease Markers|June 14, 2016
Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary FibrosisKosuke Hamai, Hiroshi Iwamoto, Nobuhisa Ishikawa, et al.
Stem Cell Research & Therapy|August 24, 2021
Antifibrotic effect of lung-resident progenitor cells with high aldehyde dehydrogenase activityHiroshi Takahashi, Taku Nakashima, Takeshi Masuda, et al.
Case Reports in Oncology|February 10, 2021
Two Cases of Cranial Nerve Metastasis Treated with Radiotherapy and Chemotherapy in Patients with Lung AdenocarcinomaErika Kobayashi, Takeshi Masuda, Satoshi Nakao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 25, 2002
Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathyGo Hiasa, Mareomi Hamada, Yuji Shigematsu, et al.
International Journal of Cancer|March 8, 2008
Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitorsNobuhisa Ishikawa, Noboru Hattori, Akihoto Yokoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2017
[A Case of Central Diabetes Insipidus That Was Caused by Pituitary Metastasis of Lung Adenocarcinoma and Was Controlled by Radiation Therapy]Yusuke Izumi, Takeshi Masuda, Shinji Nabeshima, et al.
Respiratory Research|July 28, 2011
Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung diseaseShigeo Kawase, Noboru Hattori, Nobuhisa Ishikawa, et al.
Plos One|June 4, 2021
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosisYu Nakanishi, Yasushi Horimasu, Kakuhiro Yamaguchi, et al.
Thoracic Cancer|September 29, 2021
Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reportsNaokazu Watari, Kakuhiro Yamaguchi, Takeshi Masuda, et al.
Pageof 18